STOCKHOLM, Feb. 11, 2026 /PRNewswire/ -- Swedish Orphan Biovitrum AB (Sobi) invites investors, analysts, and other stakeholders to its upcoming Capital Markets Day (CMD), which will be held in person in Stockholm, Sweden, on 18 February 2026, starting at 13:00 CET. A live webcast will also be available for remote participants.

The CMD will feature presentations by Guido Oelkers, CEO, and members of the Management Team. Participants will have the opportunity to hear updates on Sobi's strategy and physician-led therapeutic area sessions, followed by a Q&A session. The CMD is expected to conclude at approximately 16:00 CET.

Pre-registration for attendance: click here (note pre-registration is required for onsite attendance.)

This event provides an excellent opportunity for stakeholders gain insights into the company's strategic direction ahead.

Agenda in brief:

Guido Oelkers - CEO Sobi. Ambition 2030
Lydia Abad-Franch - CMO Sobi. Pipeline and innovation at Sobi
Robert Keenan - CMO Arthrosi. Disease Deep Dive: The painful burden of severe gout
Duane Barnes, Sofiane Fahmy, Norbert Oppitz - Roundtable with Regional Heads
Professor Klaus Parhofer - Disease Deep Dive: The silent risk of sHTG
Professor Evangelos Giamarellos - Disease Deep dive: Precision medicine in sepsis
Henrik Stenqvist - CFO Sobi. Delivering Shareholder Value
Guido Oelkers - CEO Sobi. Wrap up and Q&A

Sobi
Sobi® is a global biopharma company unlocking the potential of breakthrough innovations, transforming everyday life for people living with rare diseases. Sobi has approximately 1,900 employees across Europe, North America, the Middle East, Asia and Australia. In 2025, revenue amounted to SEK 28 billion. Sobi's share (STO: SOBI) is listed on Nasdaq Stockholm. More about Sobi at sobi.com and LinkedIn.

Contacts
For details on how to contact the Sobi Investor Relations Team, please click here. For Sobi Media contacts, click here.

Gerard Tobin
Head of Investor Relations

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/swedish-orphan-biovitrum-ab/r/sobi-to-host-a-capital-markets-day-on-18-february-2026,c4305384

The following files are available for download:


 
 https://mb.cision.com/Main/14266/4305384/3926513.pdf Sobi to host a Capital Markets Day on 18
                                                          February 2026

View original content:https://www.prnewswire.co.uk/news-releases/sobi-to-host-a-capital-markets-day-on-18-february-2026-302685067.html

Tags

More Like This

Save the Date: Sobi to host a Capital Markets Day on 18 February 2026

Sobi Capital Markets Day 2026: Bringing brilliant ideas to life and building the next chapter with ambition to deliver SEK 55bn by 2030

Invitation: Sobi's Q2 2024 report

Reminder: Sobi KOL investor event: Advancing the standard of care in haemophilia

Invitation: Sobi's Q1 2024 report

Invitation: Sobi's Q3 2024 report

Invitation: Sobi's Q4 and FY 2023 report

Invitation: Sobi's Q3 2023 report